๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Quality of Care Measures for the Treatment of Bipolar Disorder

โœ Scribed by Farifteh Firoozmand Duffy; William Narrow; Joyce C. West; Laura J. Fochtmann; David A. Kahn; Trisha Suppes; John M. Oldham; John S. McIntyre; Ronald W. Manderscheid; Paul Sirovatka; Darrel Regier

Publisher
Springer US
Year
2005
Tongue
English
Weight
94 KB
Volume
76
Category
Article
ISSN
0033-2720

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Divalproex for the treatment of geriatri
Divalproex for the treatment of geriatric bipolar disorder
โœ Donald J. Mordecai; Javaid I. Sheikh; Ira D. Glick ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 60 KB ๐Ÿ‘ 2 views

Divalproex is now commonly used to treat bipolar disorder in older patients. However, it has yet to be systematically studied in this population. This report describes six older bipolar patients treated with divalproex. Of the six, ยฎve showed some improvement with divalproex alone or in combination

Summary of guideline for the treatment o
Summary of guideline for the treatment of bipolar disorder
โœ Philip B. Mitchell; Gin S. Malhi; Bernette L. Redwood; Jillian Ball ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Informa plc ๐ŸŒ English โš– 182 KB

The past decade has witnessed an extraordinary expansion of treatments available for bipolar disorder. Ten years ago, lithium was the only approved agent for this condition. Since that time, carbamazepine, valproate and olanzapine have received regulatory approval for the acute treatment of mania. C

Development of the treatment attitudes q
Development of the treatment attitudes questionnaire in bipolar disorder
โœ Sheri L. Johnson; Daniel Fulford ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 176 KB

## Abstract Despite the success of pharmacotherapy in the management of bipolar disorder, as many as oneโ€half of those in treatment discontinue their medication over time. Currently, no selfโ€report measure is available that predicts treatment engagement in bipolar disorder. The goal of the current